Table 2

Characteristics of the funding statements included in the randomised controlled trials (n=178 trials)

Overall
n (%)
Funding statement reported being:
Funded (as opposed to not funded) 171 (96)
Source(s) of funding (when reported as funded, n=171)*
Internally funded 26 (15)
Externally funded by:
  Government 99 (58)
  Private-for-profit 68 (40)
  Private not-for-profit with evidence of support by private-for-profit that is a health industry 14 (8)
  Private not-for-profit with evidence of support by private-for-profit that is not a health industry 15 (9)
  Private not-for-profit with no evidence of support by private-for-profit 25 (15)
Statement included amount of funding received2 (1)
Paper reported to be sponsored by a source different than the source of funding/support2 (1)
Paper reported information on supplies (ie, drugs, devices, equipment, samples or placebos)†
Yes, supplied by manufacturer same as funder 12 (9)
Yes, supplied by manufacturer different than funder 17 (12)
Not reported 110 (79)
  • *More than one type could apply for trials reporting more than one source of funding.

  • †Calculated using the number of trials on pharmacological interventions and surgical/invasive procedures (n=139).